Publication: Clinical Features and Outcomes of 49 Turkish Patients with Acute Promyelocytic Leukemia Who Received ATRA and Anthracyclines (PETHEMA Protocol) Therapy
| dc.contributor.author | Serefhanoglu, Songul | |
| dc.contributor.author | Buyukasik, Yahya | |
| dc.contributor.author | Goker, Hakan | |
| dc.contributor.author | Sayinalp, Nilgun | |
| dc.contributor.author | Haznedaroglu, Ibrahim Celalettin | |
| dc.contributor.author | Aksu, Salih | |
| dc.contributor.author | Ozdemir, Evren | |
| dc.contributor.authorID | Haznedaroglu, Ibrahim C./0000-0001-8028-9462 | |
| dc.date.accessioned | 2020-06-21T14:46:42Z | |
| dc.date.available | 2020-06-21T14:46:42Z | |
| dc.date.issued | 2010 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Serefhanoglu, Songul -- Buyukasik, Yahya -- Goker, Hakan -- Sayinalp, Nilgun -- Haznedaroglu, Ibrahim Celalettin -- Aksu, Salih -- Ozcebe, Osman Ilhami] Hacettepe Univ, Sch Med, Dept Internal Med, Div Hematol, TR-06100 Ankara, Turkey | en_US |
| dc.description.abstract | … | en_US |
| dc.identifier.doi | 10.1016/j.leukres.2010.07.027 | |
| dc.identifier.endpage | E319 | en_US |
| dc.identifier.issn | 0145-2126 | |
| dc.identifier.issue | 12 | en_US |
| dc.identifier.pmid | 20696473 | |
| dc.identifier.startpage | E317 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.leukres.2010.07.027 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/17640 | |
| dc.identifier.volume | 34 | en_US |
| dc.identifier.wos | WOS:000283845900002 | |
| dc.language.iso | en | en_US |
| dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
| dc.relation.journal | Leukemia Research | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Clinical Features and Outcomes of 49 Turkish Patients with Acute Promyelocytic Leukemia Who Received ATRA and Anthracyclines (PETHEMA Protocol) Therapy | en_US |
| dc.type | Letter | en_US |
| dspace.entity.type | Publication |
